DK137333B - Fremgangsmåde til fremstilling af en optisk aktiv (+)-lacton. - Google Patents

Fremgangsmåde til fremstilling af en optisk aktiv (+)-lacton.

Info

Publication number
DK137333B
DK137333B DK348873AA DK348873A DK137333B DK 137333 B DK137333 B DK 137333B DK 348873A A DK348873A A DK 348873AA DK 348873 A DK348873 A DK 348873A DK 137333 B DK137333 B DK 137333B
Authority
DK
Denmark
Prior art keywords
lactone
preparation
optically active
optically
active
Prior art date
Application number
DK348873AA
Other languages
Danish (da)
English (en)
Other versions
DK137333C (US06373033-20020416-M00035.png
Inventor
Yasuhiko Aoki
Hiroyuki Suzuki
Hisao Akiyama
Shigeru Okano
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6303272A external-priority patent/JPS5516435B2/ja
Priority claimed from JP3391273A external-priority patent/JPS5335076B2/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Priority to DK362675A priority Critical patent/DK139155B/da
Publication of DK137333B publication Critical patent/DK137333B/da
Application granted granted Critical
Publication of DK137333C publication Critical patent/DK137333C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK348873AA 1972-06-22 1973-06-22 Fremgangsmåde til fremstilling af en optisk aktiv (+)-lacton. DK137333B (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK362675A DK139155B (da) 1972-06-22 1975-08-11 Fremgangsmåde til fremstilling af en optisk aktiv (+)-thiolacton.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6303272A JPS5516435B2 (US06373033-20020416-M00035.png) 1972-06-22 1972-06-22
JP3391273A JPS5335076B2 (US06373033-20020416-M00035.png) 1973-03-23 1973-03-23

Publications (2)

Publication Number Publication Date
DK137333B true DK137333B (da) 1978-02-20
DK137333C DK137333C (US06373033-20020416-M00035.png) 1978-07-24

Family

ID=26372681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK348873AA DK137333B (da) 1972-06-22 1973-06-22 Fremgangsmåde til fremstilling af en optisk aktiv (+)-lacton.

Country Status (13)

Country Link
US (1) US3876656A (US06373033-20020416-M00035.png)
AT (1) AT325038B (US06373033-20020416-M00035.png)
CA (1) CA1020561A (US06373033-20020416-M00035.png)
CH (2) CH602740A5 (US06373033-20020416-M00035.png)
DD (2) DD111577A5 (US06373033-20020416-M00035.png)
DE (1) DE2331244C3 (US06373033-20020416-M00035.png)
DK (1) DK137333B (US06373033-20020416-M00035.png)
FR (1) FR2197887B1 (US06373033-20020416-M00035.png)
GB (2) GB1420510A (US06373033-20020416-M00035.png)
HU (1) HU167852B (US06373033-20020416-M00035.png)
NL (1) NL7308766A (US06373033-20020416-M00035.png)
PL (1) PL90072B1 (US06373033-20020416-M00035.png)
SE (1) SE413245B (US06373033-20020416-M00035.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5315076B2 (US06373033-20020416-M00035.png) * 1973-09-27 1978-05-22
JPS603387B2 (ja) * 1980-07-10 1985-01-28 住友化学工業株式会社 新規光学活性イミダゾリジン−2−オン誘導体およびその製法
EP0173185B1 (de) * 1984-08-25 1990-01-31 MERCK PATENT GmbH Verfahren zur Herstellung von (3a5,6aR)-und/oder(3aR,6a5)-1,3-Dibenzyl-hexahydro-1H-furo(3,4-d)imidazol-2,4-dion
CH670644A5 (US06373033-20020416-M00035.png) * 1986-12-18 1989-06-30 Lonza Ag
DE4107121C1 (US06373033-20020416-M00035.png) * 1991-03-06 1992-06-11 Merck Patent Gmbh, 6100 Darmstadt, De
US6495125B2 (en) * 1999-01-08 2002-12-17 The Procter & Gamble Company Topical compositions comprising protected functional thiols
CN100381443C (zh) * 2003-10-23 2008-04-16 浙江医药股份有限公司新昌制药厂 一种酰亚胺衍生物的制备方法
CN103242342B (zh) * 2013-04-27 2015-09-16 浙江新和成股份有限公司 1,3-烷基四氢噻吩并[3,4-d]咪唑-2(3H)-4-二酮化合物的制备方法
US10689349B2 (en) 2016-08-04 2020-06-23 Tokuyama Corporation Method for producing intermediate of biotin and method for producing biotin
CN107686488B (zh) * 2016-08-05 2020-04-28 浙江医药股份有限公司新昌制药厂 一种生物素中间体的合成方法
JP6856471B2 (ja) * 2017-01-04 2021-04-07 株式会社トクヤマ ラクトン化合物の製造方法、および該ラクトン化合物を使用したビオチンの製造方法
WO2021066043A1 (ja) 2019-10-01 2021-04-08 株式会社トクヤマ トリオン化合物の製造方法
CN115557958B (zh) * 2021-07-02 2024-05-28 浙江医药股份有限公司新昌制药厂 一种制备生物素中间体光学活性内酯的方法
CN114790211B (zh) * 2022-04-22 2023-11-17 浙江花园营养科技有限公司 一种生物素及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687967A (en) * 1969-02-24 1972-08-29 Hoffmann La Roche {60 -dehydrobiotin synthesis
US3700659A (en) * 1970-11-17 1972-10-24 Hoffmann La Roche (+)-cis - 1,3-dibenzyl-hexahydro-1h-furo-(3,4-d)imidazole - 2,4 - dione,processes and intermediates

Also Published As

Publication number Publication date
DD111577A5 (US06373033-20020416-M00035.png) 1975-02-20
SE413245B (sv) 1980-05-12
FR2197887A1 (US06373033-20020416-M00035.png) 1974-03-29
CH593286A5 (US06373033-20020416-M00035.png) 1977-11-30
CH602740A5 (US06373033-20020416-M00035.png) 1978-07-31
DK137333C (US06373033-20020416-M00035.png) 1978-07-24
CA1020561A (en) 1977-11-08
DD107932A5 (US06373033-20020416-M00035.png) 1974-08-20
DE2331244B2 (de) 1977-07-14
US3876656A (en) 1975-04-08
GB1420509A (en) 1976-01-07
AT325038B (de) 1975-09-25
NL7308766A (US06373033-20020416-M00035.png) 1973-12-27
DE2331244C3 (de) 1978-03-02
GB1420510A (en) 1976-01-07
PL90072B1 (en) 1976-12-31
DE2331244A1 (de) 1974-01-10
FR2197887B1 (US06373033-20020416-M00035.png) 1977-07-29
HU167852B (US06373033-20020416-M00035.png) 1975-12-25

Similar Documents

Publication Publication Date Title
DK138951B (da) Fremgangsmåde til fremstilling af N-phosphonomethyl-glycin.
DK134607B (da) Fremgangsmåde til fremstilling af rapamycin.
DK137329B (da) Analogifremgangsmåde til fremstilling af 2-karbalkoksyaminobenzimidazolderivater.
DK140340B (da) Analogifremgangsmåde til fremstilling af benzoxazolderivater.
DK135775B (da) Analogifremgangsmåde til fremstilling af mættede 3alfa-hydroxy-5alfa-pregnaner.
DK131868B (da) Analogifremgangsmåde til fremstilling af tri-p-toluensulfonatet af S-adenosyl-L-methionin.
DK138537B (da) Analogifremgangsmåde til fremstilling af carbazoler.
DK137333B (da) Fremgangsmåde til fremstilling af en optisk aktiv (+)-lacton.
DK134604B (da) Fremgangsmåde til fremstilling af indenyl-3-acetoglucuronider.
DK138898B (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin.
DK138230B (da) Analogifremgangsmåde til fremstilling af vincanolsalte.
DK138796B (da) Analogifremgangsmåde til fremstilling af 2-carboxypyrazin-4-oxidderivater.
DK132233B (da) Fremgangsmåde til fremstilling af antibiotikum A-2315.
DK131864B (da) Fremgangsmåde til fremstilling af pregnan-21-syrederivater.
DK138645B (da) Analogifremgangsmåde til fremstilling af sulfamoylfenyl-imidazolidiner.
DK131575B (da) Analogifremgangsmåde til fremstilling af 2beta-hydroxy-3alfa-aminosteroider.
DK135122B (da) Analogifremgangsmåde til fremstilling af 4-aryl-5-aminoalkyl-4-oxazolin-2-onderivater.
DK138988B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive morphinanderivater.
DK135166B (da) Analogifremgangsmåde til fremstilling af 2-methyl-5-nitro-imidazoler.
DK129657B (da) Analogifremgangsmåde til fremstilling af 3-methylpyrazol-5-carboxamider.
DK134236B (da) Analogifremgangsmåde til fremstilling af 3-cycloalkoxy-16alfa-cyanopregn-5-en-20-oner.
DK132410B (da) Analogifremgangsmåde til fremstilling af 2-amino-4H-pyraner.
DK139677B (da) Fremgangsmåde til fremstilling af 7-benzoylindolin-2-oner.
DK131579B (da) Fremgangsmåde til fremstilling af en amylaseinhibitor.
DK131041B (da) Fremgangsmåde til fremstilling af et antibiotikumkompleks.

Legal Events

Date Code Title Description
PBP Patent lapsed